Therefore, platelet-derived miR-223 after incorporated into VSMCs at least in part suppress VSMC proliferation via targeting IGF-1R and activating AMPK to reduce neointimal hyperplasia in DM. This evidence concerns the gene PRKAB1 and diabetes mellitus.